NUMENTUS TECHNOLOGIES INC
Menlo Park, CA · Medtech · Private
High-throughput fluorescence imaging platform for single-particle analysis of bacterial outer membrane vesicles (OMVs) and extracellular vesicles, correlating surface proteins and nucleic acid cargoes
- Grants
- $2.4M
- 8 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2021202220232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Single Exosome Technology for Alzheimer's Disease | $299,151 | |
| Federal grant | Department of Health and Human Services · Phase I · Single Exosome Technology for Alzheimer's Disease | $299,151 | |
| Federal grant | Department of Health and Human Services · Phase I · Very rapid, low cost multiplexed test for SARS, Influenza A and Influenza B Resubmission | $285,597 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Bacteria and pathogen characterizations using outer membrane vesicles | $298,794 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Bacteria and pathogen characterizations using outer membrane vesicles | $298,794 | |
| Federal grant | Department of Health and Human Services · Phase I · High-speed hyperspectral imaging for highly multiplexed immunofluorescence imaging | $300,691 | |
| Federal grant | Department of Health and Human Services · Phase I · Rapid, versatile PCR | $297,872 | |
| Federal grant | Department of Health and Human Services · Phase I · High-Throughput High-Content Nanoscale Extracellular Vesicle Analysis | $298,999 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 680 | STARK STREET MATERIALS COMPANY | — | — |
| 681 | BIOGRAFT, INC. | — | — |
| 682 | ZIMMER BIOMET HOLDINGS, INC. | — | $216M |
| 683 | NUMENTUS TECHNOLOGIES INC | — | — |
| 684 | ECATE LLC | — | — |
| 685 | THERMOBIONICS L.L.C. | — | — |
| 686 | ACCURE HEALTH INC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.